Dr. George R. Blumenschein
Claim this profileMD Anderson Cancer Center
Studies Pancreatic Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
18 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
ALK positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials George R. Blumenschein is currently running
MYTX-011
for Lung Cancer
This trial is testing MYTX-011, a new medication that targets advanced lung cancer cells with specific genetic markers. It uses an antibody to guide a powerful drug directly to the cancer cells to kill them.
Recruiting1 award Phase 19 criteria
SGN-EGFRd2
for Advanced Cancer
This study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in participants with advanced solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that cannot be removed (unresectable) or has spread through the body (metastatic). This study will have three parts. Parts A and B of the study will find out how much PF-08046052/SGN-EGFRd2 should be given to participants. Part C will use the dose found in parts A and B to find out how safe PF-08046052/SGN-EGFRd2 is and if it works to treat solid tumor cancers.
Recruiting1 award Phase 13 criteria
More about George R. Blumenschein
Clinical Trial Related18 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments George R. Blumenschein has experience with
- Carboplatin
- Paclitaxel
- Sorafenib
- IMC-C103C
- Atezolizumab
- Aldesleukin
Breakdown of trials George R. Blumenschein has run
Pancreatic Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George R. Blumenschein specialize in?
George R. Blumenschein focuses on Pancreatic Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is George R. Blumenschein currently recruiting for clinical trials?
Yes, George R. Blumenschein is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that George R. Blumenschein has studied deeply?
Yes, George R. Blumenschein has studied treatments such as Carboplatin, Paclitaxel, Sorafenib.
What is the best way to schedule an appointment with George R. Blumenschein?
Apply for one of the trials that George R. Blumenschein is conducting.
What is the office address of George R. Blumenschein?
The office of George R. Blumenschein is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.